AAPL338.40-2.67 (-0.78%) ▼|ABBV266.28+1.94 (+0.73%) ▲|ABT100.98-0.31 (-0.31%) ▼|ACN174.47-1.64 (-0.93%) ▼|ADBE231.01-4.46 (-1.89%) ▼|AMAT486.76+1.76 (+0.36%) ▲|AMD607.87-22.76 (-3.61%) ▼|AMGN418.13+3.52 (+0.85%) ▲|AMT168.00-1.03 (-0.61%) ▼|AMZN246.15-3.52 (-1.41%) ▼|AVGO349.57-3.24 (-0.92%) ▼|AXP306.33-2.56 (-0.83%) ▼|BA184.39-13.68 (-6.91%) ▼|BAC55.47-1.23 (-2.17%) ▼|BKNG163.87-0.08 (-0.05%) ▼|BLK1,071.25-15.06 (-1.39%) ▼|BMY63.88+1.02 (+1.62%) ▲|BNY148.44-1.71 (-1.14%) ▼|BRK-B503.09-2.39 (-0.47%) ▼|C131.31-2.97 (-2.21%) ▼|CAT819.95-1.63 (-0.20%) ▼|CL86.52+0.46 (+0.53%) ▲|CMCSA21.79-0.12 (-0.55%) ▼|COF196.46-3.74 (-1.87%) ▼|COP126.04-1.26 (-0.99%) ▼|COST922.92+0.16 (+0.02%) ▲|CRM227.27-6.75 (-2.88%) ▼|CSCO106.74+0.04 (+0.04%) ▲|CVS87.85-1.28 (-1.44%) ▼|CVX206.37+1.92 (+0.94%) ▲|DE689.59-0.87 (-0.13%) ▼|DHR227.33+2.84 (+1.27%) ▲|DIS105.59-0.56 (-0.53%) ▼|DUK113.41+0.06 (+0.05%) ▲|EMR159.39+1.16 (+0.73%) ▲|FDX289.65+3.80 (+1.33%) ▲|GD334.16-2.56 (-0.76%) ▼|GE318.24-8.85 (-2.71%) ▼|GEV949.77-7.86 (-0.82%) ▼|GILD152.21+1.28 (+0.85%) ▲|GM80.64-1.99 (-2.41%) ▼|GOOG339.16-1.92 (-0.56%) ▼|GOOGL342.75-1.17 (-0.34%) ▼|GS916.28-19.17 (-2.05%) ▼|HD289.89-3.31 (-1.13%) ▼|HON211.52-1.03 (-0.48%) ▼|IBM220.67-4.84 (-2.15%) ▼|INTC116.03-6.97 (-5.67%) ▼|INTU269.40-6.39 (-2.32%) ▼|ISRG414.79+9.61 (+2.37%) ▲|JNJ271.95+0.73 (+0.27%) ▲|JPM336.59-6.47 (-1.89%) ▼|KO87.18-0.63 (-0.72%) ▼|LIN472.04+2.15 (+0.46%) ▲|LLY1,184.78+1.32 (+0.11%) ▲|LMT518.10-1.46 (-0.28%) ▼|LOW187.66-1.62 (-0.86%) ▼|LRCX314.47-0.74 (-0.23%) ▼|MA568.26+0.61 (+0.11%) ▲|MCD233.60-2.90 (-1.23%) ▼|MDLZ60.18-0.07 (-0.12%) ▼|MDT89.50+0.86 (+0.97%) ▲|META715.62-36.04 (-4.79%) ▼|MMM169.48-0.07 (-0.04%) ▼|MO69.13+0.31 (+0.45%) ▲|MRK148.69-0.09 (-0.06%) ▼|MS193.64-2.67 (-1.36%) ▼|MSFT509.22-6.95 (-1.35%) ▼|MU1,053.98-28.30 (-2.61%) ▼|NEE75.49-0.59 (-0.78%) ▼|NFLX69.23-1.92 (-2.69%) ▼|NKE36.39+0.64 (+1.79%) ▲|NOW131.45-4.17 (-3.07%) ▼|NVDA228.86+3.79 (+1.68%) ▲|ORCL132.60-4.50 (-3.28%) ▼|PEP128.50-0.13 (-0.10%) ▼|PFE28.72+0.05 (+0.17%) ▲|PG149.03+2.80 (+1.91%) ▲|PLTR187.48-2.19 (-1.15%) ▼|PM193.76+3.28 (+1.72%) ▲|QCOM187.48-14.49 (-7.17%) ▼|RTX187.66-1.74 (-0.92%) ▼|SBUX95.27+0.41 (+0.43%) ▲|SCHW98.30-0.73 (-0.74%) ▼|SO82.35-0.53 (-0.64%) ▼|SPG204.53-0.29 (-0.14%) ▼|T24.90-0.48 (-1.89%) ▼|TMO678.60+3.60 (+0.53%) ▲|TMUS166.45+1.02 (+0.62%) ▲|TSLA357.45-14.66 (-3.94%) ▼|TXN278.31+0.24 (+0.09%) ▲|UBER68.16-1.46 (-2.10%) ▼|UNH377.83+1.24 (+0.33%) ▲|UNP274.10+0.31 (+0.11%) ▲|UPS94.25+0.29 (+0.31%) ▲|USB58.78-0.55 (-0.93%) ▼|V367.74+0.36 (+0.10%) ▲|VZ46.68-0.40 (-0.85%) ▼|WFC80.81-2.16 (-2.60%) ▼|WMT108.73+0.75 (+0.69%) ▲|XOM162.52+1.93 (+1.20%) ▲|AAPL338.40-2.67 (-0.78%) ▼|ABBV266.28+1.94 (+0.73%) ▲|ABT100.98-0.31 (-0.31%) ▼|ACN174.47-1.64 (-0.93%) ▼|ADBE231.01-4.46 (-1.89%) ▼|AMAT486.76+1.76 (+0.36%) ▲|AMD607.87-22.76 (-3.61%) ▼|AMGN418.13+3.52 (+0.85%) ▲|AMT168.00-1.03 (-0.61%) ▼|AMZN246.15-3.52 (-1.41%) ▼|AVGO349.57-3.24 (-0.92%) ▼|AXP306.33-2.56 (-0.83%) ▼|BA184.39-13.68 (-6.91%) ▼|BAC55.47-1.23 (-2.17%) ▼|BKNG163.87-0.08 (-0.05%) ▼|BLK1,071.25-15.06 (-1.39%) ▼|BMY63.88+1.02 (+1.62%) ▲|BNY148.44-1.71 (-1.14%) ▼|BRK-B503.09-2.39 (-0.47%) ▼|C131.31-2.97 (-2.21%) ▼|CAT819.95-1.63 (-0.20%) ▼|CL86.52+0.46 (+0.53%) ▲|CMCSA21.79-0.12 (-0.55%) ▼|COF196.46-3.74 (-1.87%) ▼|COP126.04-1.26 (-0.99%) ▼|COST922.92+0.16 (+0.02%) ▲|CRM227.27-6.75 (-2.88%) ▼|CSCO106.74+0.04 (+0.04%) ▲|CVS87.85-1.28 (-1.44%) ▼|CVX206.37+1.92 (+0.94%) ▲|DE689.59-0.87 (-0.13%) ▼|DHR227.33+2.84 (+1.27%) ▲|DIS105.59-0.56 (-0.53%) ▼|DUK113.41+0.06 (+0.05%) ▲|EMR159.39+1.16 (+0.73%) ▲|FDX289.65+3.80 (+1.33%) ▲|GD334.16-2.56 (-0.76%) ▼|GE318.24-8.85 (-2.71%) ▼|GEV949.77-7.86 (-0.82%) ▼|GILD152.21+1.28 (+0.85%) ▲|GM80.64-1.99 (-2.41%) ▼|GOOG339.16-1.92 (-0.56%) ▼|GOOGL342.75-1.17 (-0.34%) ▼|GS916.28-19.17 (-2.05%) ▼|HD289.89-3.31 (-1.13%) ▼|HON211.52-1.03 (-0.48%) ▼|IBM220.67-4.84 (-2.15%) ▼|INTC116.03-6.97 (-5.67%) ▼|INTU269.40-6.39 (-2.32%) ▼|ISRG414.79+9.61 (+2.37%) ▲|JNJ271.95+0.73 (+0.27%) ▲|JPM336.59-6.47 (-1.89%) ▼|KO87.18-0.63 (-0.72%) ▼|LIN472.04+2.15 (+0.46%) ▲|LLY1,184.78+1.32 (+0.11%) ▲|LMT518.10-1.46 (-0.28%) ▼|LOW187.66-1.62 (-0.86%) ▼|LRCX314.47-0.74 (-0.23%) ▼|MA568.26+0.61 (+0.11%) ▲|MCD233.60-2.90 (-1.23%) ▼|MDLZ60.18-0.07 (-0.12%) ▼|MDT89.50+0.86 (+0.97%) ▲|META715.62-36.04 (-4.79%) ▼|MMM169.48-0.07 (-0.04%) ▼|MO69.13+0.31 (+0.45%) ▲|MRK148.69-0.09 (-0.06%) ▼|MS193.64-2.67 (-1.36%) ▼|MSFT509.22-6.95 (-1.35%) ▼|MU1,053.98-28.30 (-2.61%) ▼|NEE75.49-0.59 (-0.78%) ▼|NFLX69.23-1.92 (-2.69%) ▼|NKE36.39+0.64 (+1.79%) ▲|NOW131.45-4.17 (-3.07%) ▼|NVDA228.86+3.79 (+1.68%) ▲|ORCL132.60-4.50 (-3.28%) ▼|PEP128.50-0.13 (-0.10%) ▼|PFE28.72+0.05 (+0.17%) ▲|PG149.03+2.80 (+1.91%) ▲|PLTR187.48-2.19 (-1.15%) ▼|PM193.76+3.28 (+1.72%) ▲|QCOM187.48-14.49 (-7.17%) ▼|RTX187.66-1.74 (-0.92%) ▼|SBUX95.27+0.41 (+0.43%) ▲|SCHW98.30-0.73 (-0.74%) ▼|SO82.35-0.53 (-0.64%) ▼|SPG204.53-0.29 (-0.14%) ▼|T24.90-0.48 (-1.89%) ▼|TMO678.60+3.60 (+0.53%) ▲|TMUS166.45+1.02 (+0.62%) ▲|TSLA357.45-14.66 (-3.94%) ▼|TXN278.31+0.24 (+0.09%) ▲|UBER68.16-1.46 (-2.10%) ▼|UNH377.83+1.24 (+0.33%) ▲|UNP274.10+0.31 (+0.11%) ▲|UPS94.25+0.29 (+0.31%) ▲|USB58.78-0.55 (-0.93%) ▼|V367.74+0.36 (+0.10%) ▲|VZ46.68-0.40 (-0.85%) ▼|WFC80.81-2.16 (-2.60%) ▼|WMT108.73+0.75 (+0.69%) ▲|XOM162.52+1.93 (+1.20%) ▲|
16.5 C
New York
Tuesday, September 29, 2026

Tag: time

newssourceFORcompanyinformationcontent1releasesmarket

ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware

WINSTON-SALEM, N.C., July 01, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced the completion of the domestication process to change the jurisdiction of incorporation of the Company from the Cayman Islands to Delaware. The domestication was approved by shareholders of the Company at its Annual General Meeting held on May 29, 2025. Effective as of July 1, 2025, each (i) Class A ordinary share automatically converted into one share of Class A common stock of ProKidney Corp., a Delaware corporation and (ii) each Class B ordinary share automatically converted into one share of Class B common stock of ProKidney. ProKidney common stock will begin trading on July 2, 2025, and the Company's trading symbol on the Nasdaq Stock Market will remain unchanged as "PROK." The Company’s CUSIP number relating to its Class A common stock changed to 74291D 104. The Company does not anticipate any impact to day-to-day business operations as a result of the domestication.

Texas Instruments to webcast Q2 2025 earnings conference call

DALLAS, July 1, 2025 /PRNewswire/ -- Texas Instruments Incorporated (TI) (Nasdaq: TXN) will webcast its second quarter 2025 earnings conference call on Tuesday, July 22,...

Helping heroes RISE: Wounded vets thrive in accessible smart homes

DALLAS, July 1, 2025 /PRNewswire/ -- "Freedom and security are precious gifts that we, as Americans, should never take for granted. We must do...

AuditBoard Appoints Raul Villar Jr. as Chief Executive Officer

Seasoned executive brings high-growth, enterprise experience at scale to fuel customer-focused, international expansion LOS ANGELES, July 1, 2025 /PRNewswire/ -- AuditBoard, the leading AI-powered...

Populus Financial Group Partners with Junior Achievement to Teach Students Financial Literacy

DALLAS, July, 1, 2025 /PRNewswire/ -- Populus Financial Group, Inc. (Populus) volunteers taught the JA in a Day program to 739 students at J.O. Davis...

Harrison Ford entertainingly reveals Glenmorangie as Official Whisky of Formula 1®

- "Nice", says actor in witty verdict on whisky's pioneering partnership -  GLASGOW, Scotland, July 1, 2025 /PRNewswire/ -- Glenmorangie Highland single malt Scotch whisky...

Transaction in Own Shares

Transaction in Own Shares

Direct Meds Launches Company-Wide AI Program to Scale Patient Care Amid Explosive Growth

Direct Meds LLC, a fast-scaling telemedicine provider serving the US and Canada, today announced a company-wide deployment of artificial intelligence (AI).

RedHill Biopharma Announces Recruitment Initiated into Expanded Phase 2 Opaganib/Darolutamide Combination Study in Advanced Prostate Cancer

Recruitment initiated into the Phase 2 opaganib plus darolutamide study in patients with advanced prostate cancer, sponsored by ANZUP, and supported by Bayer and...

Zedonk Launches Z.Studio: A Standalone Tech Pack Builder

LONDON, July 1, 2025 /PRNewswire/ -- Today, Zedonk, a leading cloud-based ERP and fashion PLM software provider announces the launch of Z.Studio, a standalone platform built...

Louise de Putron Donates $1 Million to Pivotal to Transform Lives of Foster Youth through Scholarships and Mental Health Support

The gift will support foster youth as they pursue their academic and career goals, and establish a new Mental Health fund SAN JOSE, Calif., July...

T-Pain and Clinton Sparks Officially Launch the Global Gaming League in Las Vegas

The Star-Studded Kickoff Event Hosted by Nick Cannon and Jermaine Dupri featured a Performance by Social Media Pioneer Soulja Boy 
 The Star-Studded Kickoff Event Hosted by Nick Cannon and Jermaine Dupri featured a Performance by Social Media Pioneer Soulja Boy

Will XRP reach $5? PBK Miner expands XRP mining contracts to meet surging investment demand

XRP momentum is strong as the $5 price target comes into focus. PBK Miner’s new XRP mining contracts offer investors a unique opportunity for daily passive income and long-term asset growth. 
XRP momentum is strong as the $5 price target comes into focus. PBK Miner’s new XRP mining contracts offer investors a unique opportunity for daily passive income and long-term asset growth.

Cold Jet Unlocks Significant New Revenue Opportunities for RNG Biomethane Sites Through Advanced Carbon Capture and Dry Ice Production

Cold Jet enables RNG biomethane sites to turn CO2 emissions into high-value dry ice, unlocking significant new revenue streams.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsTime

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers